New Oropharyngeal Human Papillomavirus PCR Test Helps Screen For Oropharyngeal Cancer

Posted: December 5, 2022
Edited by Dentaltown staff

PASADENA, Calif.—OmniPathology, an independent, physician-owned and operated pathology lab, announced the launch of a new oral test for human papillomavirus (HPV) that can cause cancer. The Oral HPV Test is a lab-developed test (LDT) performed on high-throughput platforms.

The Oral HPV Test detects 14 high-risk strains of HPV. It is performed via a throat swab submitted to OmniPathology, a CLIA-certified laboratory in Pasadena, for testing. This test will be offered to primary care and GYN physicians, LGBTQIA+ clinics, dentists, oral surgeons, and ENT practices across the country as part of routine examinations of patients.

For more information about the new Oral HPV Test, please contact OmniPathology at omnipathology.com/closer-look.

Sponsors
Townie Perks
Townie® Poll
Does your practice screen for sleep apnea?
  
Sally Gross, Member Services Specialist
Phone: +1-480-445-9710
Email: sally@farranmedia.com
©2023 Dentaltown, a division of Farran Media • All Rights Reserved
9633 S. 48th Street Suite 200 • Phoenix, AZ 85044 • Phone:+1-480-598-0001 • Fax:+1-480-598-3450